Samuel R. Perry

Brigham and Women's Hospital

Publishes on HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, PI3K/AKT/mTOR signaling in cancer. 38 papers and 6.6k citations.

38Publications

6.6kTotal Citations

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research PI3K/AKT/mTOR signaling in cancer Pancreatic and Hepatic Oncology Research MicroRNA in disease regulation

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism

Haoqiang Ying, Alec C. Kimmelman, Costas A. Lyssiotis et al.|Cell|2012

Cited by 2kOpen Access

Telomere dysfunction induces metabolic and mitochondrial compromise

Ergün Sahin, Simona Colla, Marc Liesa et al.|Nature|2011

Cited by 1.3k

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

Hongwu Zheng, Haoqiang Ying, Haiyan Yan et al.|Nature|2008

Cited by 763Open Access

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

Zhihu Ding, Chang‐Jiun Wu, Gerald C. Chu et al.|Nature|2011

Cited by 525Open Access

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al.|Cancer Cell|2016

Cited by 387Open Access